CRISPR screening libraries are collections of carefully designed single-guide RNAs (sgRNAs) that allow researchers to ...

Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing ...

Our writer thinks these two speculative shares offer high long-term growth potential from where they currently sit in the ...

Infertility is a major global challenge associated with physiological and psychological impact. Genetic mutations that affect early embryonic ...

CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

Mars is a strange place and any humans born there are bound to look radically different over thousands or even hundreds of ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...

Orna Therapeutics and Vertex will use lipid nanoparticle system to develop gene-editing therapies for people with SCD and TDT ...

If we assume all patients who began treatment with Casgevy last year progress to the administration stage, CRISPR and Vertex ...

Researchers at the University of Texas at San Antonio (UTSA) are tackling some of the biggest challenges facing older adults ...

The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...